HMOX1 and endothelial dysfunction: Incretin-based therapies also exhibited beneficial effects on lipoprotein metabolism.31,32 Apart from the effects on lipid parameters, sitagliptin and incretin-based therapies could improve oxidative stress and heme oxygenase-1, reduce markers of systemic inflammation, and improve endothelial dysfunction.33,34